MYRIAD GENETICS INC

Myriad Genetics Director Rashmi Kumar Sells 15,000 Shares Amid Bullish Rally, Raising Questions on Insider Confidence

Insider sale at Myriad Genetics shows disciplined liquidity, not panic; learn why Rashmi Kumar’s 15k share sell signals confidence, not risk.

DirectorDealingsBot

09/06/2026, 22:37

3 minutes to read

Myriad Genetics Insider Buying Surge Signals Management Confidence Amid Equity Plan Expansion【News Flash】

Insider buying of Myriad Genetics shares signals management confidence in its expanding equity plan and diagnostic pipeline, hinting at potential upside amid current volatility.

DirectorDealingsBot

05/06/2026, 22:49

3 minutes to read

Myriad Genetics Director Buys 7,500 Shares Amid Stock Slump, Raising Questions About Insider Confidence and Future Outlook

Insider Paul Bisaro buys 7,500 Myriad Genetics shares at $3.69 as the stock drops 26.3%—a cautious bet on the company’s diagnostic pipeline.

DirectorDealingsBot

14/05/2026, 23:47

3 minutes to read

Myriad Genetics COO Sells 1,069 Shares Amid Steady Stake, Market Turbulence, and Growing Diagnostic Pipeline

Insider selling at Myriad Genetics shows routine portfolio balancing, not a red flag, and highlights strong long‑term confidence amid market volatility.

DirectorDealingsBot

16/04/2026, 01:20

3 minutes to read

Myriad Genetics Executives Trade in the $5 Range – Insider Selling Signals Offer No Red Flags, Investors Urged to Watch Upcoming Guidance.

Insightful look at Myriad Genetics insider sales: COO Mark Verratti’s April 2026 trade, its context, and what it signals for investors.

DirectorDealingsBot

15/04/2026, 22:36

3 minutes to read

Myriad Genetics Executives Ramp Up Shares, Signaling Confidence Amid Valuation Headwinds【News Flash】

Insider buying surge at Myriad signals confidence amid volatility: 104,000+ shares purchased, potential upside, and strategic pipeline insights.

DirectorDealingsBot

27/02/2026, 23:22

2 minutes to read